Quality Systems – Page 287

Homogeneity Failure after supplier change: how QA should write CAPA for inspectors

Managing Homogeneity Failures Post-Supplier Change: A Guide for Quality Assurance In the realm of pharmaceutical manufacturing, ensuring product homogeneity is crucial for both compliance and therapeutic efficacy. A common issue…

Crystallization In Syrup after supplier change: water system and sanitation checks

Identifying and Addressing Crystallization in Syrups Following Supplier Changes In the pharmaceutical manufacturing landscape, the integrity of liquid oral dosage forms, such as syrups, is paramount. A recent challenge arises…

Preservative Under-Dosing during method transfer: manufacturing vs lab root cause decision tree

Understanding the Root Cause of Preservative Under-Dosing during Method Transfer in Pharmaceutical Manufacturing In pharmaceutical manufacturing, particularly within liquid oral dosage forms such as syrups and suspensions, the precision of…

Homogeneity Failure after supplier change: water system and sanitation checks

Dealing with Homogeneity Issues after Supplier Transition: An Investigation Framework In pharmaceutical manufacturing, supplier changes can introduce variability that may lead to significant product quality issues, including homogeneity failures. Such…

Fill Volume Variability after temperature excursion: manufacturing vs lab root cause decision tree

Investigating Fill Volume Variability After Temperature Excursion: A Manufacturing and Lab Decision Tree Fill volume variability can lead to significant compliance issues within pharmaceutical manufacturing, especially following a temperature excursion.…

Hold Time Bioburden Rise during scale-up: water system and sanitation checks

Investigating the Rise of Hold Time Bioburden during Scale-up: Essential Checks for Water Systems and Sanitation In the realm of pharmaceutical manufacturing, the rise of bioburden during hold times poses…

Crystallization In Syrup in syrup production: packaging and transport risk assessment

Assessing Risks of Crystallization in Syrup Production: An Investigation Framework In the pharmaceutical manufacturing of liquid oral dosage forms, particularly syrups, the occurrence of crystallization poses significant challenges. These challenges…

Homogeneity Failure during method transfer: manufacturing vs lab root cause decision tree

Decision Tree for Investigating Homogeneity Failure during Method Transfer in Pharmaceutical Manufacturing In pharmaceutical manufacturing, ensuring drug formulation homogeneity is vital for both safety and efficacy, especially during method transfer.…

Tag: Quality Systems

Homogeneity Failure after supplier change: how QA should write CAPA for inspectors

Crystallization In Syrup after supplier change: water system and sanitation checks

Preservative Under-Dosing during method transfer: manufacturing vs lab root cause decision tree

Homogeneity Failure after supplier change: water system and sanitation checks

Fill Volume Variability after temperature excursion: manufacturing vs lab root cause decision tree

Hold Time Bioburden Rise during scale-up: water system and sanitation checks

Crystallization In Syrup in syrup production: packaging and transport risk assessment

Homogeneity Failure during method transfer: manufacturing vs lab root cause decision tree

Viscosity Drift during method transfer: manufacturing vs lab root cause decision tree

Assay Oos during method transfer: investigation flowchart aligned to GMP

Ph Drift during filling line setup: packaging and transport risk assessment

Density Mismatch during bulk hold: packaging and transport risk assessment